Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000898432-25-000584·Amneal Pharmaceuticals, Inc.
Schedule 13D ownership disclosure
Amneal Pharmaceuticals Inc
Class A Common Stock, par value $0.01 · CUSIP: 03168L105
Event date: 2025-08-06
- Filing-level shares
- 22,180,421
- Percent of class
- 7.1%
- Patel Chirag K.Reported CIK 0001738701
Shares: 22,180,421 · Class: 7.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000898432-25-000584
- Form type
- SCHEDULE 13D/A
- Filer
- Amneal Pharmaceuticals, Inc.
- CIK
- CIK 1723128
- Filed
- Aug 08, 2025
- Reporting period
- Aug 06, 2025
- Description
- Schedule 13D beneficial ownership